LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $833,000 | -9.3% | 7,300 | 0.0% | 0.31% | -8.8% |
| Q1 2019 | $918,000 | -84.7% | 7,300 | -87.0% | 0.34% | -90.9% |
| Q4 2018 | $5,998,000 | -18.5% | 56,300 | +60.9% | 3.72% | +6.4% |
| Q3 2018 | $7,363,000 | +1.6% | 35,000 | 0.0% | 3.50% | +25.7% |
| Q2 2018 | $7,250,000 | +4.5% | 35,000 | -16.7% | 2.78% | +2.9% |
| Q1 2018 | $6,936,000 | +74.7% | 42,000 | +44.8% | 2.71% | +93.3% |
| Q4 2017 | $3,971,000 | +0.6% | 29,000 | 0.0% | 1.40% | -8.9% |
| Q3 2017 | $3,946,000 | +261.0% | 29,000 | +222.2% | 1.54% | +270.1% |
| Q2 2017 | $1,093,000 | +14.8% | 9,000 | 0.0% | 0.42% | +14.0% |
| Q1 2017 | $952,000 | -68.8% | 9,000 | -70.0% | 0.36% | -73.5% |
| Q4 2016 | $3,048,000 | – | 30,000 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |